VEGFA and age-related macular degeneration: As control, we used the 28-nt non-PEGylated oligonucleotide of Macugen, an anti-VEGF therapeutic RNA aptamer approved for the treatment of age-related macular degeneration,43 containing multiple ribose 2′-O-methyl and 2′–fluoro modifications.